Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma.

Veldman, Johanna; Visser, Lydia; Berg, Anke van den; Diepstra, Arjan

Veldman, Johanna; Visser, Lydia; Berg, Anke van den; Diepstra, Arjan.

Afiliação

Veldman J; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700RB Groningen, the Netherlands.
Visser L; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700RB Groningen, the Netherlands.
Berg AVD; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700RB Groningen, the Netherlands.
Diepstra A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9700RB Groningen, the Netherlands. Electronic address: a.diepstra@umcg.nl.

Cancer Treat Rev ; 82: 101931, 2020 Jan.

Article em En | MEDLINE | ID: mdl-31756590

Assuntos

Doença de Hodgkin; Terapia de Alvo Molecular; Receptor de Morte Celular Programada 1/antagonistas & inibidores; Resistencia a Medicamentos Antineoplásicos/imunologia; Doença de Hodgkin/tratamento farmacológico; Doença de Hodgkin/imunologia; Humanos; Terapia de Alvo Molecular/efeitos adversos; Terapia de Alvo Molecular/métodos; Evasão Tumoral/imunologia

Palavras-chave

Antigen presentation; Hodgkin lymphoma; Immune checkpoint inhibitors; PD-1 inhibitors; Resistance mechanisms; Tumor immunology

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Terapia de Alvo Molecular / Receptor de Morte Celular Programada 1 Limite: Humans Idioma: En Revista: Cancer Treat Rev Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google